Sectors

SoftBank Vision Fund made its first investment in Baidu's online education spinoff as part of a series E round reportedly set to value it at $6.5bn pre-money.

Facit exited McMaster University's cancer radiotherapy spinout in an upsized initial public offering after $158m in funding.

OneProjects, an irregular heartbeat imaging system developer assisted by two Irish universities, will use the cash to pursue commercialisation in the US.

University of Kent's UltraSoc Technologies, which provides integrated circuit safety technologies, has agreed to an acquisition by Siemens.

The health insurance provider pushed its overall funding past $1.5bn in a late-stage round that included long-term investor Alphabet.

The hearing loss treatment developer, which counts Novartis Venture Fund and Partners Innovation Fund as investors, floated above its range.

The endpoint management software provider has secured roughly $120m from strategic partner Salesforce, bumping its valuation up from $6.5bn to $9bn.

Johnson & Johnson and Varian Medical exited the cancer radiotherapy developer in an upsized initial public offering after $158m in funding.

Novartis and Transposagen-backed gene and cell therapy developer Poseida Therapeutics closed the series D round two days after filing to go public.

Hogil Doh has ascended to a chief operating officer position at Yahoo Japan’s investment arm, after joining in February from fellow corporate venturing unit Rakuten Ventures.

Nestlé Health Science and Takeda participated in a series E round for Enterome, which received $52.6m in equity and debt financing through the deal.